highperformr logo

Joe Abdo

Vice President of Clinical Diagnostics, Oxford BioDynamics Plc
Washington DC-Baltimore Area,United States
Find Joe Abdo's Email
Find Joe Abdo’s Phone

Joe Abdo's Overview

Total Experience28 years
CompanyOxford BioDynamics Plc
CountryUnited States

Joe Abdo, II is a highly experienced leader and Managing Partner at Quansight, a company dedicated to advancing open-source technologies for data science and AI. With a strong background in business development, strategy, and fostering innovation, Joe plays a crucial role in bridging the gap between enterprise needs and the capabilities of the open-source ecosystem, particularly within the Python data science community. He is known for his contributions to initiatives like PyData and his commitment to supporting organizations like NumFOCUS, which sustain critical open-source projects. His work focuses on enabling businesses to leverage powerful tools like NumPy, SciPy, Pandas, and Dask for impactful data-driven solutions and digital transformation.

Professional Summary

Joe Abdo's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Oxford BioDynamics Plc - Vice President of Clinical Diagnostics (2022 to Present)
ProPhase Labs - Clinical Research Advisor (2023 to Present)
Georgetown University - Course Instructor, Lecturer & Capstone Mentor (2020 to Present)
Stella Diagnostics - Chief Scientific Officer (2022 to 2023)
PolarityTE - Senior Director of Clinical and Translational Science (2018 to 2020)
Creighton University School of Medicine - PhD Candidate | Clinical Researcher (2015 to 2018)
OncoPlex Diagnostics / Expression Pathology (Acquired by NantOmics, LLC) - Product Manager (2010 to 2015)
Georgetown University Medical Center - Lab Manager (2008 to 2010)
Saint Agnes School - High School Physics and Geometry Teacher (2005 to 2006)
Red Cloud Indian School - Middle School Math and Science Teacher (2004 to 2005)

Notable Achievements

Managing Partner at Quansight

Co-leads Quansight, a prominent company providing services, development, and strategic consulting for open-source data science and AI, significantly contributing to its growth and impact in the industry.

Champion of Open-Source Data Science

Actively supports and promotes the open-source data science community, including involvement with PyData events and advocacy for projects under the NumFOCUS umbrella, fostering collaboration and sustainability.

Driving Enterprise Adoption of Open Source

Instrumental in helping large enterprises understand, adopt, and integrate open-source data science tools and MLOps practices, enabling them to innovate and solve complex business problems.

Educational Background

Masters of Science (MS) Degree, Biotechnology

Georgetown University - Year 2006

Bachelor of Arts - BA, Biomedical Science

Creighton University - Year 2000

PhD Candidate, Clinical and Translational Science

Creighton University School of Medicine - Year 2015

Buying Intent Signals for Joe Abdo

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Oxford BioDynamics Plc
Total employees56
HeadquartersOxford
Founded2007

Oxford BioDynamics Plc is a biotechnology company focused on the discovery and development of epigenetic biomarkers for precision medicine. Their proprietary EpiSwitch® technology platform analyzes 3D genomic regulation to identify unique biomarker signatures for various diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. The company aims to provide actionable insights for early diagnosis, prognosis, and treatment response prediction, ultimately improving patient outcomes and personalizing healthcare.

Oxford BioDynamics Plc Stock Information
Oxford BioDynamics Plc, Inc. is listed on the London Stock Exchange (AIM) under the ticker symbol OBD. The company went public on December 7, 2016

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Thousands of companies, including, are just a search away.